Women with polycystic ovary syndrome (PCOS) are at increased risk for dysglycemia and type 2 diabetes compared to healthy BMI-matched women of reproductive age: robust evidence exists supporting this notion. The presence of altered glycemic status in young women with the syndrome presents a distinct challenge for the clinician for several reasons. Firstly, the reported incidence of this disorder varies among the limited available studies. Furthermore, there is a lack of consensus on the best screening method, which women to screen, at what frequency, and which strategies need to be implemented to reduce the above risk. We provide data regarding the prevalence of dysglycemia in young women suffering from PCOS and the pathophysiological mechanisms underlying the disorder. In addition, we present evidence suggesting universal screening with the oral glucose tolerance test in young women with the syndrome, irrespective of age or BMI status, to identify and manage glycemic abnormalities in a timely manner. Regarding follow-up, oral glucose testing should be carried out at regular intervals if there are initial abnormal findings or predisposing factors. Finally, the efficacy of a well-balanced diet in conjunction with regular exercise and the use of non-pharmacologic agents in this specific population is discussed.

Livadas, S., Paparodis, R., Anagnostis, P., Gambineri, A., Bjekić-Macut, J., Petrović, T., et al. (2023). Assessment of Type 2 Diabetes Risk in Young Women with Polycystic Ovary Syndrome. DIAGNOSTICS, 13(12), 13-25 [10.3390/diagnostics13122067].

Assessment of Type 2 Diabetes Risk in Young Women with Polycystic Ovary Syndrome

Gambineri, Alessandra;
2023

Abstract

Women with polycystic ovary syndrome (PCOS) are at increased risk for dysglycemia and type 2 diabetes compared to healthy BMI-matched women of reproductive age: robust evidence exists supporting this notion. The presence of altered glycemic status in young women with the syndrome presents a distinct challenge for the clinician for several reasons. Firstly, the reported incidence of this disorder varies among the limited available studies. Furthermore, there is a lack of consensus on the best screening method, which women to screen, at what frequency, and which strategies need to be implemented to reduce the above risk. We provide data regarding the prevalence of dysglycemia in young women suffering from PCOS and the pathophysiological mechanisms underlying the disorder. In addition, we present evidence suggesting universal screening with the oral glucose tolerance test in young women with the syndrome, irrespective of age or BMI status, to identify and manage glycemic abnormalities in a timely manner. Regarding follow-up, oral glucose testing should be carried out at regular intervals if there are initial abnormal findings or predisposing factors. Finally, the efficacy of a well-balanced diet in conjunction with regular exercise and the use of non-pharmacologic agents in this specific population is discussed.
2023
Livadas, S., Paparodis, R., Anagnostis, P., Gambineri, A., Bjekić-Macut, J., Petrović, T., et al. (2023). Assessment of Type 2 Diabetes Risk in Young Women with Polycystic Ovary Syndrome. DIAGNOSTICS, 13(12), 13-25 [10.3390/diagnostics13122067].
Livadas, Sarantis; Paparodis, Rodis; Anagnostis, Panagiotis; Gambineri, Alessandra; Bjekić-Macut, Jelica; Petrović, Tijana; Yildiz, Bulent O.; Micić, ...espandi
File in questo prodotto:
File Dimensione Formato  
diagnostics2023.pdf

accesso aperto

Tipo: Versione (PDF) editoriale
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione 531.71 kB
Formato Adobe PDF
531.71 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/956466
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 6
  • ???jsp.display-item.citation.isi??? 6
social impact